Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Cigna (CI.N) said on Monday it will remove AbbVie’s (ABBV.N), opens new tab blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead.